Novel endocytosis inhibitors block entry of HIV-1 Tat into neural cells
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00723.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Olga Klaudia Szewczyk-Roszczenko und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Synthesis and Technology of Drugs, Medical University of Białystok, Białystok, Poland. Hauptthemen laut MEDLINE: Endocytosis, tat Gene Products, Human Immunodeficiency Virus, Neurons, HIV-1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uniwersytet Medyczny w Bialymstoku (Medical University of Bialystok), Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS), Ligue Contre le Cancer (French League Against Cancer).
Abstract (Originalsprache)
This study identifies novel rhodadyn-based inhibitors, Les-6631 and Les-6633, which selectively block dynamin’s GTPase activity while sparing clathrin-mediated pathways. They effectively inhibit cellular uptake, protect neural cells from HIV-1 Tat-induced oxidative stress, and reduce mitochondrial and DNA damage. Their selective dynamin inhibition and antioxidant properties highlight their therapeutic potential for neurodegeneration and viral infections, offering cell protection without disrupting essential endocytic functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Synthesis and Technology of Drugs, Medical University of Białystok, Białystok, Poland.
- Department of Biotechnology, Medical University of Białystok, Białystok, Poland.
- CNRS UMR9018, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.
- Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
- Department of Chemistry, Taras Shevchenko National University, Kyiv, Ukraine.
- Enamine Ltd, Kyiv, Ukraine.
ORCID-Profile: Olga Klaudia Szewczyk-Roszczenko, Yegor Vassetzky
Förderung
- Uniwersytet Medyczny w Bialymstoku (Medical University of Bialystok)
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS)
- Ligue Contre le Cancer (French League Against Cancer)
- National Research Foundation of Ukraine
Zitieren
APA
Szewczyk-Roszczenko, O. K., Roszczenko, P., Shmakova, A., Yushyn, I., Holota, S., Karpenko, O., Czarnomysy, R., Bielawska, A., Vassetzky, Y., Lesyk, R., & Bielawski, K. (2025). Novel endocytosis inhibitors block entry of HIV-1 Tat into neural cells. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00723.2024
Vancouver
Szewczyk-Roszczenko OK, Roszczenko P, Shmakova A, Yushyn I, Holota S, Karpenko O, et al. Novel endocytosis inhibitors block entry of HIV-1 Tat into neural cells. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00723.2024
BibTeX
@article{SzewczykRoszczenko2025,
author = {Szewczyk-Roszczenko, Olga Klaudia and Roszczenko, Piotr and Shmakova, Anna and Yushyn, Ihor and Holota, Serhii and Karpenko, Olexandr and Czarnomysy, Robert and Bielawska, Anna and Vassetzky, Yegor and Lesyk, Roman and Bielawski, Krzysztof},
title = {Novel endocytosis inhibitors block entry of HIV-1 Tat into neural cells},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00723.2024}
}
EUVIMED